Pharmacotherapy for Postprandial Hyperglycemia in Type 2 Diabetes / 임상당뇨병

ABSTRACT

A growing body of evidence shows that effective postprandial hyperglycemia management in individuals with type 2 diabetes can reduce the risk of diabetic complications and cardiovascular diseases. Therefore, accurate monitoring and effective intervention for postprandial hyperglycemia is very important in routine clinical practice for type 2 diabetes. Therapeutic modalities for the management of postprandial hyperglycemia include oral antidiabetic drugs (alpha glucosidase inhibitor, meglitinide, dipeptidyl peptidase-IV inhibitor), ultra-short-acting insulin analogues, and incretin mimetics. A detailed understanding of the advantages and disadvantages of various pharmacotherapies and a careful understanding of the underlying physical and social situations of each patient will be of great help to determine the appropriate prescription for postprandial hyperglycemia management.